Metraipolis › archive › dc_bc78e87d2744

Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter,… — Europe PMC PMID:41388935

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41388935
DOI
10.1002/cam4.71469
License (as archived)
solo-consultazione
Archived
2026-11-08T01:56:43.013Z
SHA-256 of the archived text
c581046fa6a067f00d61f6782463a57fcc3e84532c2814e9111fb329ce519bec
Stable URL of this page
https://metraipolis.com/documento/dc_bc78e87d2744

How to cite

Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter,… — Europe PMC PMID:41388935 — Europe PMC (en), https://europepmc.org/article/MED/41388935 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc78e87d2744 (Metraipolis archive dc_bc78e87d2744, sha256 c581046fa6a067f00d61f6782463a57fcc3e84532c2814e9111fb329ce519bec)
BibTeX
@misc{dcbc78e87d2744,
  title = {Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter,… — Europe PMC PMID:41388935},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41388935},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc78e87d2744; sha256 c581046fa6a067f00d61f6782463a57fcc3e84532c2814e9111fb329ce519bec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41388935. Agents can read the archived copy with the MCP tool read_document.